MRK $90.97 0.21 (0.2%)

    MRK Profile

    MRK trades on the NYSE.

    MEMBERSHIP
    Dow Industrials S&P 500 Dogs Of The Dow




    Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.

    MRK Earnings


    Q2 Earnings for Apr, May & Jun

    Tue, Jul 30, 2019

    Since Earnings Report

    MRK +10.3%


    Q3 Earnings for Jul, Aug & Sep

    Tue, Oct 29, 2019

    Since Earnings Report

    MRK +10.7%

    MRK Dividend

    Dividend Yield

    2.68%

    Dividend Rate

    $2.44


    Ex-Dividend Date

    Fri, Dec 13, 2019


    Dividend Pay Date

    Wed, Jan 8, 2020



    Dividend Payments

    137 Payments


    MRK Industry Competitors


    BIOTECH & PHARMA
    Johnson & Johnson
    Pfizer
    Bristol-Myers Squibb
    Novo Nordisk A/S
    Amgen
    Eli Lilly
    AbbVie
    Sanofi SA (ADR)
    Gilead Sciences
    Celgene

    BIOTECH & PHARMA



    Symbol MC DY Price Day YTD
    MRK $233.06 2.68% $90.97 -0.2% -1.2%






        TOP    




    info@symbolsurfing.com


    Stock Market Terms

    Remove Blur With Premium Subscription

    Symbol Surfing

    ©2020 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy